Get access

Mutated ERBB4: a novel drug target in metastatic melanoma?


  • Coverage on: Prickett, T.D., Agrawal, N.S., Wei, X., et al. (2009). Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4. Nat Genet. Aug 30. (Epub ahead of print).

No abstract is available for this article.

Get access to the full text of this article